HEB

Hemispherx BioPharma

AMEX

Add Alert

208

HEB

Hemispherx BioPharma

AMEX

Add Alert

208

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

mick

11/05/20 10:36 AM

Post #15,662

Re: #15,660: @mick - Hemispherx Biopharma (HEB) NOW AIM

Hemispherx Biopharma (HEB)
1.8 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
- - - - -
HEB Detailed Quote

Richard2

11/05/20 9:30 AM

Post #15,661

Re: #15,660: @mick - Hemispherx Biopharma (HEB) NOW AIM

I liked the original name better lol. Still think this drug has great potential, but I’m disappointed there wasn’t any news from the Japan trials.

mick

04/05/20 4:08 PM

Post #15,660

Re: #15,658: @Richard2 - ‘AIM’ is the new ticker.

Hemispherx Biopharma (HEB) NOW AIM

deniseann

02/05/20 11:37 AM

Post #15,659

Re: #15,658: @Richard2 - ‘AIM’ is the new ticker.

Thank you Richard, I couldn't seem to find anything on the change...

Richard2

02/05/20 4:43 AM

Post #15,658

Re: #15,656: @deniseann - Is this still a real stock..?

‘AIM’ is the new ticker.

Richard2

02/05/20 4:42 AM

Post #15,657

Re: #15,656: @deniseann - Is this still a real stock..?

No, the company changed its name and ticker. There’s a new board.

deniseann

01/30/20 12:25 PM

Post #15,656

Is this still a real stock..?

lowfloatwayne Terminated

11/06/19 6:36 PM

Post #15,655

Re: #15,652: @lowfloatwayne - Their voting now to raise the share count

Buying all i can it may be a long haul there is probably a reason they taking shares instead of all their pay. Hopefully a buy out.

Richard2

10/28/19 11:17 AM

Post #15,654

Re: #15,653: @LW89 - They need cash so they can hit their

This drug could be huge in the me/cfs community, I really thought it would’ve received approval here in the states.

LW89

08/29/19 5:42 PM

Post #15,653

Re: #15,652: @lowfloatwayne - Their voting now to raise the share count

They need cash so they can hit their finish and fill due in October...and they need to poly-line recertified for that to happen. They are still planning to send product to Argentina (filed the paperwork) - so regardless of what they in their PRs...someone in management is still pursuing ME/CFS where they have approvals to build on.

lowfloatwayne Terminated

08/28/19 9:00 AM

Post #15,652

Re: #15,649: @lowfloatwayne - Ok their not adding shares could be a

Their voting now to raise the share count from 2018

lowfloatwayne Terminated

08/26/19 9:11 PM

Post #15,651

Re: #15,649: @lowfloatwayne - Ok their not adding shares could be a

Acusphere has twice as many shares moves ez this should rocket eiyh the right hedge or buy out merger

cspratt15139 Free

08/18/19 8:56 AM

Post #15,650

this is just sad. pure sad

lowfloatwayne Terminated

08/05/19 9:35 PM

Post #15,649

Re: #15,648: @cspratt15139 - they do this to themselves

Ok their not adding shares could be a 2008 run cant tell whats bottom they bought in at 2.30? Legally

cspratt15139 Free

07/23/19 8:36 PM

Post #15,648

Re: #15,647: @lowfloatwayne - So they rs to 2.2m shares then dilute

they do this to themselves

lowfloatwayne Terminated

07/22/19 9:48 PM

Post #15,647

So they rs to 2.2m shares then dilute 70m shares https://seekingalpha.com/article/893871-tracking-recent-buy-calls-and-investments-by-the-maxim-group
I hope the can run a pump and dump and clay can do a video.

aristotelisonassis Free

07/17/19 2:06 PM

Post #15,646

strong buy here. Bottom bouncer.

cspratt15139 Free

06/22/19 4:18 PM

Post #15,645

Hope everyone is enjoying there weekend. Stay safe and blessed!

cspratt15139 Free

06/16/19 4:15 PM

Post #15,644

Re: #15,643: @bleu22 - Fully funded trial up to 45-people, low float,

Ampligen is picking up steam

bleu22

06/16/19 3:56 PM

Post #15,643

Re: #15,642: @cspratt15139 - Going higher

Fully funded trial up to 45-people, low float, looking for large pharmaceutical partnership, and more news on the way... I’m in. GLTA

cspratt15139 Free

06/15/19 8:10 PM

Post #15,642

Going higher

420man

06/13/19 6:49 PM

Post #15,641

LOL..Can't even wait a few days to reward their Tutes via PR! And that's even after crushing retail for months. They will continue dumping all the way down helping shorty... I need to start shorting these plays. So damn predictable.

bleu22

06/12/19 9:37 PM

Post #15,640

They don’t even have options laid out yet. WTF

whytestocks Free

06/12/19 4:00 PM

Post #15,639

News: $HEB Hemispherx Biopharma Announces First Patient Treated in Phase 2 Ovarian Cancer Clinical Trial Evaluating Ampligen in Combination with Pembrolizumab and Cisplatin

OCALA, Fla., June 12, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma Inc. announced today that the first patient has been treated in the Phase 2 recurrent ovarian cancer program at the University of Pittsburgh Medical Center (UPMC) (See: https://clinicaltrials...

In case you are interested https://marketwirenews.com/news-releases/hemispherx-biopharma-announces-first-patient-treated-in-phase-2-ovarian-cancer-clinical-trial-evaluating-ampligen-in-combination-with-pembrolizumab-and-cisplatin-8346632.html

420man

06/11/19 12:11 PM

Post #15,638

There's your RS... Let the shorting begin!!!

cspratt15139 Free

06/10/19 7:30 PM

Post #15,637

Split coming

420man

06/07/19 6:31 PM

Post #15,636

.05

Golden Cross PremiumMember

06/02/19 4:42 AM

Post #15,635

How low will it go before the RS is the question? I am staying out wish all GL

whytestocks Free

05/31/19 10:30 AM

Post #15,634

News: $HEB Hemispherx Biopharma Stockholders Approve Reverse Stock Split

OCALA, Fla., May 31, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases, today announced that its stockholders voted in...

Read the whole news https://marketwirenews.com/news-releases/hemispherx-biopharma-stockholders-approve-reverse-stock-split-8277778.html

cspratt15139 Free

05/29/19 6:56 AM

Post #15,633

When is the rs

hebbeke47

05/21/19 4:02 AM

Post #15,632

https://www.mrknewsroom.com/news-release/oncology/merck-provides-update-phase-3-keynote-119-study-keytruda-pembrolizumab-monothe

carldfw

05/18/19 8:20 PM

Post #15,631

Re: #15,625: @pberger - As I said several times, no value here,

They have investors after the rs or people to buy in. They have been selling out with each pump. Hope they have a ringer in the fda. Or 10 years later the same pumps as 2008

Golden Cross PremiumMember

05/17/19 7:10 PM

Post #15,630

HEB Daily Chart:

whytestocks Free

05/06/19 9:50 AM

Post #15,629

News: $HEB Hemispherx Links Stanford's ME/CFS Diagnostic to a Potential Path Forward for Ampligen Commercialization

OCALA, Fla., May 06, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma Inc., (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases — and whose product portfolio includes Amp...

In case you are interested https://marketwirenews.com/news-releases/hemispherx-links-stanford-s-me-cfs-diagnostic-to-a-potential-path-forward-for-ampligen-commercialization-8123236.html

Golden Cross PremiumMember

05/06/19 9:10 AM

Post #15,628

HEB on High Alert

tknuncle

05/03/19 8:53 PM

Post #15,627

Re: #15,626: @420man - So the warrant exercise price has been reduced

WOW that's insane!!!! Thanks for sharing the actual numbers ;)

420man

05/03/19 7:41 PM

Post #15,626

So the warrant exercise price has been reduced to .15?! These guys are sucker punching retail! They would be delisted already if they traded on the the NAZ. JMO

The following table illustrates the dilution:

Offering price per share $0.15
Net tangible book value per share as of December 31, 2018 $(0.0875 )
Increase in net tangible book value per share after this offering $(0.0041)
Pro forma net tangible book value per share after this offering $(0.916 )

Dilution per share to the investor in this offering $0.0584

pberger

05/03/19 7:56 AM

Post #15,625

Re: #15,622: @nokomis - price of warrants reduced to .15 bearish

As I said several times, no value here, but pure CRAP.

ClayTrader Free

05/02/19 4:41 PM

Post #15,624

* * $HEB Video Chart 05-02-2019 * *

Link to Video - click here to watch the technical chart video

Golden Cross PremiumMember

05/02/19 10:17 AM

Post #15,623

Re: #15,622: @nokomis - price of warrants reduced to .15 bearish

sinking fast here

nokomis

05/02/19 10:14 AM

Post #15,622

Re: #15,618: @Golden Cross - Nice news today!

price of warrants reduced to .15 bearish

pberger

05/02/19 9:53 AM

Post #15,621

This pure CRAP is now below the "good news" from 2 days ago, such a TURD!!!

Golden Cross PremiumMember

05/02/19 9:09 AM

Post #15,620

Nasty... Looking to buy back in on a big dip today

ClayTrader Free

05/01/19 4:57 PM

Post #15,619

* * $HEB Video Chart 05-01-2019 * *

Link to Video - click here to watch the technical chart video

Golden Cross PremiumMember

05/01/19 9:48 AM

Post #15,618

Re: #15,611: @whytestocks - News: $HEB Hemispherx To Be Transparent on the

Nice news today!

Zarate69

05/01/19 9:48 AM

Post #15,617

Dilution pure....

tknuncle

05/01/19 9:42 AM

Post #15,616

Where are all these shares coming from? It seems we have gone through all the OS after yesterday and this morning. We don't know what the float is but reading the OS at the OTC. So again were are all these shares coming from? The flippers have to be out now. Are the Shares being shorted by
the MM's? Again too new to trading to know what is going on with HEB..I would appreciate any input ;)

aidytrader Free

05/01/19 9:23 AM

Post #15,615

Re: #15,614: @TommyBoyTrader9460 - $heb..huge news out today..shorts scrambling premarket...

Where is the news? Thanks

TommyBoyTrader9460 Free

05/01/19 9:13 AM

Post #15,614

Re: #15,608: @$avvyPenny$tockInvestor™ - May get a nice bounce tomorrow.

$heb..huge news out today..shorts scrambling premarket...

JJGl

05/01/19 8:58 AM

Post #15,613

26s!!

Older

Hemispherx BioPharma (HEB)

Followers	208	Posters	912
Posts (Today)	0	Posts (Total)	15662
Created	12/05/06	Type	Free
Moderators

Hemispherx BioPharma (HEB)

Stephen Thorpe has been added as Chief Operating Officer – HEMISPHERX BIOPHARMA INC
Mr Thorpe with his background in Building Medical equipment and many years in production automation will be an asset to us. Factor in his extreme devotion to dogs and how he cannot be bullied off a life long meat and potato diet, he has everytrhing you can ask for in a guy to lean on for technical advice and know how.

WILLIAM CARTER – HEMISPHERX BIOPHARMA INC

R. WILLIAM CARTER has served as Chief Scientific Officer of Hemispherx Biopharma, Inc., since May 1989, the Chairman of the company's Board of Directors since January 1992, the company's Chief Executive Officer since July 1993, the company's President since April 1995, and a Director since 1987. He is the co-inventor of Ampligen', joined the company in 1978, and from 1987 to 1988, he served as the company's Chairman. Dr. Carter was a leading innovator in the development of human interferon for a variety of treatment indications including various viral diseases and cancer. In this context, he received the first FDA approval to initiate clinical trials on a beta interferon product manufactured in the US under his supervision. From 1985 to October 1988, Dr. Carter served as the company's Chief Executive Officer and Chief Scientist. He received his MD degree from Duke University and underwent his post-doctoral training at the National Institutes of Health and Johns Hopkins University. Dr. Carter also served as Professor of Neoplastic Diseases at Hahnemann Medical University, a position he held from 1980 to 1998. He also served as Director of Clinical Research for Hahnemann Medical University's Institute for Cancer and Blood Diseases, and as a Professor at Johns Hopkins School of Medicine and the State University of New York at Buffalo. He is a Board certified physician and author of more than 200 scientific articles, including the editing of various textbooks on anti-viral and immune therapy

PIPELINE.

Commercial Products

Country: USA

PRODUCT NAME	CATEGORY	COMMERICAL STATUS

Alferon N Injection®	Genital HPV (condylomata acuminata)	Sales anticipated to resume upon successful pre-approval inspection and supplemental approval by FDA

Country: Argentina

PRODUCT NAME	CATEGORY	COMMERICAL STATUS

Alferon N Injection®	Genital HPV (condylomata acuminata)	Approved. Launch pending manufacturing approval

Alferon N Injection®	Refractory to Recombinant IFN	Approved. Launch pending manufacturing approval

Rintatolimod (U.S. Tradename: Ampligen®)	Severe Cases of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)	Approved. Launch pending

Product Candidate

Country

Indication

Ampligen®	USA	CFS/ME

Ampligen®	USA	HIV

Ampligen®	USA	Metastatic Melanoma

Ampligen®	USA	Renal Cell Carcinoma

Ampligen®	European Union	Ebola Virus Disease

Alferon N Injection®	European Union	MERS

Most Liked Posts
(Last 30 Days)

No Liked Posts in the last 30 Days

Volume:
Day Range:
Last Trade Time:

Delayed by 15 minutes

Detailed Quote

HEB Latest News

No Recent News Available for this company!

More HEB News

New Post

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community